[go: up one dir, main page]

GB0625783D0 - Medicament - Google Patents

Medicament

Info

Publication number
GB0625783D0
GB0625783D0 GBGB0625783.6A GB0625783A GB0625783D0 GB 0625783 D0 GB0625783 D0 GB 0625783D0 GB 0625783 A GB0625783 A GB 0625783A GB 0625783 D0 GB0625783 D0 GB 0625783D0
Authority
GB
United Kingdom
Prior art keywords
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0625783.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Queens University of Belfast
Original Assignee
Queens University of Belfast
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Queens University of Belfast filed Critical Queens University of Belfast
Priority to GBGB0625783.6A priority Critical patent/GB0625783D0/en
Publication of GB0625783D0 publication Critical patent/GB0625783D0/en
Priority to PCT/GB2007/005010 priority patent/WO2008078109A2/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0625783.6A 2006-12-22 2006-12-22 Medicament Ceased GB0625783D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0625783.6A GB0625783D0 (en) 2006-12-22 2006-12-22 Medicament
PCT/GB2007/005010 WO2008078109A2 (en) 2006-12-22 2007-12-24 Medicament

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0625783.6A GB0625783D0 (en) 2006-12-22 2006-12-22 Medicament

Publications (1)

Publication Number Publication Date
GB0625783D0 true GB0625783D0 (en) 2007-02-07

Family

ID=37758951

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0625783.6A Ceased GB0625783D0 (en) 2006-12-22 2006-12-22 Medicament

Country Status (2)

Country Link
GB (1) GB0625783D0 (en)
WO (1) WO2008078109A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9353150B2 (en) 2012-12-04 2016-05-31 Massachusetts Institute Of Technology Substituted pyrazino[1′,2′:1 ,5]pyrrolo[2,3-b]-indole-1,4-diones for cancer treatment
WO2015042239A1 (en) 2013-09-19 2015-03-26 Massachusetts Institute Of Technology Compounds, compositions and methods of agelastatin alkaloids
US10918627B2 (en) 2016-05-11 2021-02-16 Massachusetts Institute Of Technology Convergent and enantioselective total synthesis of Communesin analogs
US11932650B2 (en) 2017-05-11 2024-03-19 Massachusetts Institute Of Technology Potent agelastatin derivatives as modulators for cancer invasion and metastasis
US10640508B2 (en) 2017-10-13 2020-05-05 Massachusetts Institute Of Technology Diazene directed modular synthesis of compounds with quaternary carbon centers
US11535634B2 (en) 2019-06-05 2022-12-27 Massachusetts Institute Of Technology Compounds, conjugates, and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines and uses thereof
WO2022182415A1 (en) 2021-02-24 2022-09-01 Massachusetts Institute Of Technology Himastatin derivatives, and processes of preparation thereof, and uses thereof
CA3218791A1 (en) * 2021-05-11 2022-11-17 Baylor University Agelastatin a derivatives and related methods

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004106343A2 (en) * 2003-05-30 2004-12-09 Ufc Limited Agelastatin derivatives of antitumour and gsk-3beta-inhibiting alkaloids
WO2006055578A2 (en) * 2004-11-16 2006-05-26 Temple University - Of The Commonwealth Systems Of Higher Education Asymmetric synthesis of (-)-agelastatin a

Also Published As

Publication number Publication date
WO2008078109A2 (en) 2008-07-03
WO2008078109A3 (en) 2009-09-11

Similar Documents

Publication Publication Date Title
GB0620359D0 (en) Medical devices
IL195247A0 (en) Inhaler
HUE038232T2 (en) Inhaler
GB2436526B (en) Syringe
ZA200806318B (en) Drug combinations
GB2434754B (en) Inhaler
GB0603926D0 (en) Syringes
EP2015810A4 (en) Improved syringe
IL197883A0 (en) Combination drug
GB0608046D0 (en) Syringe
GB0617134D0 (en) Medical devices
GB0625783D0 (en) Medicament
GB0717450D0 (en) Medicament
AP2006000208S (en) Inhaler
GB0613031D0 (en) Medicaments
GB0615064D0 (en) Medicament
ZA200809732B (en) Single use syringe
GB0615814D0 (en) Medicament
ZA200708369B (en) Medicament
GB0608996D0 (en) Drug counter
TWM292546U (en) Medicament counter
AU311491S (en) Inhaler
ZA200902756B (en) Combination drug
GB0622332D0 (en) Drug
GB0625433D0 (en) Pharmaceutical combinations

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)